- Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
-
Ghorbanihaghjo A, Argani H, Golmohamadi Z, Rashtchizadeh N, Abbasi MM, Bargahi N, Vatankhah , Sanajou D
- KMID: 2419842
- J Bone Metab.
- 2018 Aug;25(3):153-159.
- doi: 10.11005/jbm.2018.25.3.153
BACKGROUND: High serum phosphate and fibroblast growth factor-23 (FGF-23) levels are well-recognized independent risk factors of mortality and morbidity in patients with chronic kidney diseases (CKDs). Sevelamer, as a phosphate... -
- CITED
-
- Close
- SHARE
-
- Close
